These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2823201)

  • 1. Small cell carcinoma of the lung: interaction with the blood coagulation mechanism and treatment with anticoagulants.
    Zacharski LR
    Onkologie; 1987 Aug; 10(4):264-70. PubMed ID: 2823201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basis for selection of anticoagulant drugs for therapeutic trials in human malignancy.
    Zacharski LR
    Haemostasis; 1986; 16(3-4):300-20. PubMed ID: 3019848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75.
    Zacharski LR; Henderson WG; Rickles FR; Forman WB; Cornell CJ; Forcier RJ; Edwards RL; Headley E; Kim SH; O'Donnell JF
    Cancer; 1984 May; 53(10):2046-52. PubMed ID: 6322957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-specific sites of fibrinogen in small cell carcinoma of the lung.
    Zacharski LR; Memoli VA; Rousseau SM
    Cancer; 1988 Jul; 62(2):299-302. PubMed ID: 2838152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic role of coagulation in small cell lung cancers].
    LeBeau B
    Rev Mal Respir; 1996; 13(1):21-6. PubMed ID: 8650412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coagulation and bronchopulmonary cancers: from clinical aspects to biology].
    Brechot JM; Conard J; Samama M
    Rev Mal Respir; 1992; 9(4):375-84. PubMed ID: 1324514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of blood coagulation factors in situ in small cell carcinoma of the lung.
    Zacharski LR; Memoli VA; Rousseau SM; Kisiel W
    Cancer; 1987 Dec; 60(11):2675-81. PubMed ID: 2824013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.
    Maurer LH; Herndon JE; Hollis DR; Aisner J; Carey RW; Skarin AT; Perry MC; Eaton WL; Zacharski LL; Hammond S; Green MR
    J Clin Oncol; 1997 Nov; 15(11):3378-87. PubMed ID: 9363869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism and cancer.
    Zacharski LR; Ornstein DL
    N Engl J Med; 2000 Nov; 343(18):1338. PubMed ID: 11183567
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75.
    Zacharski LR; Henderson WG; Rickles FR; Forman WB; Cornell CJ; Forcier RJ; Edwards R; Headley E; Kim SH; O'Donnell JR; O'Dell R; Tornyos K; Kwaan HC
    JAMA; 1981 Feb; 245(8):831-5. PubMed ID: 6257941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin anticoagulation for small-cell lung cancer: evidence against a cytotoxic or anticoagulant mechanism.
    Silberberg JM; Zucker S
    J Clin Oncol; 1990 Jan; 8(1):182-4. PubMed ID: 2153191
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon.
    Wojtukiewicz MZ; Zacharski LR; Moritz TE; Hur K; Edwards RL; Rickles FR
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):429-37. PubMed ID: 1330024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of current and emerging antithrombotics in thrombosis and cancer.
    Mousa SA
    Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cancer with anticoagulants: rationale in the treatment of melanoma.
    Ornstein DL; Zacharski LR
    Int J Hematol; 2001 Feb; 73(2):157-61. PubMed ID: 11372726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
    Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.
    Altinbas M; Coskun HS; Er O; Ozkan M; Eser B; Unal A; Cetin M; Soyuer S
    J Thromb Haemost; 2004 Aug; 2(8):1266-71. PubMed ID: 15304029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with anticoagulant and antiplatelet therapies.
    Zacharski LR; Meehan KR; Algarra SM; Calvo FA
    Cancer Metastasis Rev; 1992 Nov; 11(3-4):421-31. PubMed ID: 1423826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
    Chahinian AP; Propert KJ; Ware JH; Zimmer B; Perry MC; Hirsh V; Skarin A; Kopel S; Holland JF; Comis RL
    J Clin Oncol; 1989 Aug; 7(8):993-1002. PubMed ID: 2547030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin for small-cell lung cancer: why not?
    Zacharski LR; Henderson WG
    J Clin Oncol; 1990 Jul; 8(7):1282-3. PubMed ID: 2162913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.